CONFALONIERI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 18.142
EU - Europa 14.406
AS - Asia 13.143
SA - Sud America 2.298
AF - Africa 435
OC - Oceania 109
Continente sconosciuto - Info sul continente non disponibili 15
AN - Antartide 1
Totale 48.549
Nazione #
US - Stati Uniti d'America 17.667
SG - Singapore 4.604
RU - Federazione Russa 3.712
IT - Italia 3.097
CN - Cina 2.630
PL - Polonia 1.849
BR - Brasile 1.739
VN - Vietnam 1.541
HK - Hong Kong 1.513
SE - Svezia 832
FR - Francia 825
DE - Germania 808
KR - Corea 774
GB - Regno Unito 618
TR - Turchia 567
FI - Finlandia 392
UA - Ucraina 392
IE - Irlanda 379
NL - Olanda 372
BG - Bulgaria 345
IN - India 335
CA - Canada 200
MX - Messico 186
JP - Giappone 168
AR - Argentina 161
ES - Italia 150
BD - Bangladesh 135
AT - Austria 126
MA - Marocco 113
CH - Svizzera 105
ID - Indonesia 103
CO - Colombia 101
AU - Australia 94
IQ - Iraq 94
PK - Pakistan 90
ZA - Sudafrica 88
EC - Ecuador 83
BE - Belgio 70
SA - Arabia Saudita 66
PH - Filippine 55
TH - Thailandia 55
CL - Cile 54
IR - Iran 54
TW - Taiwan 54
VE - Venezuela 47
PY - Paraguay 46
HU - Ungheria 43
GR - Grecia 41
EG - Egitto 39
UZ - Uzbekistan 39
IL - Israele 38
SN - Senegal 35
RO - Romania 34
PE - Perù 33
CZ - Repubblica Ceca 30
PT - Portogallo 30
MY - Malesia 29
TN - Tunisia 29
KE - Kenya 27
DZ - Algeria 26
JO - Giordania 25
SI - Slovenia 25
LT - Lituania 24
AZ - Azerbaigian 22
AE - Emirati Arabi Uniti 21
ET - Etiopia 21
HR - Croazia 21
NO - Norvegia 19
UY - Uruguay 19
NP - Nepal 17
OM - Oman 15
KZ - Kazakistan 14
NZ - Nuova Zelanda 14
TT - Trinidad e Tobago 14
AO - Angola 13
CR - Costa Rica 13
EU - Europa 13
RS - Serbia 13
PA - Panama 12
BO - Bolivia 11
DK - Danimarca 11
JM - Giamaica 10
LB - Libano 10
LK - Sri Lanka 9
NG - Nigeria 9
AL - Albania 8
DO - Repubblica Dominicana 8
HN - Honduras 8
BH - Bahrain 7
GA - Gabon 7
GE - Georgia 7
PS - Palestinian Territory 7
CI - Costa d'Avorio 6
GT - Guatemala 6
KG - Kirghizistan 6
LA - Repubblica Popolare Democratica del Laos 6
LV - Lettonia 6
MD - Moldavia 6
BB - Barbados 5
BY - Bielorussia 5
Totale 48.455
Città #
Moscow 3.432
Singapore 2.731
Ashburn 1.879
Warsaw 1.607
Hong Kong 1.464
Fairfield 1.433
San Jose 1.241
Chandler 1.005
Woodbridge 882
Wilmington 797
Seoul 734
Houston 722
Trieste 691
Seattle 655
Beijing 535
Princeton 516
Cambridge 506
Ho Chi Minh City 504
Hefei 494
Ann Arbor 483
Boardman 465
Jacksonville 423
Chicago 410
Izmir 393
Columbus 366
Hanoi 364
Dublin 349
Sofia 339
Lauterbourg 326
Council Bluffs 311
Los Angeles 280
Dallas 278
Wellsboro 275
Santa Clara 261
The Dalles 251
London 244
Helsinki 217
Milan 202
Zgierz 199
São Paulo 161
Frankfurt am Main 154
New York 151
Rome 113
San Diego 113
Munich 110
Tokyo 102
Lappeenranta 85
Redwood City 85
Buffalo 84
Redmond 78
Vienna 78
Casablanca 77
Nuremberg 76
Dong Ket 71
Rio de Janeiro 67
Dearborn 65
Guangzhou 64
North Bergen 64
Da Nang 62
Haiphong 62
Orem 59
Shanghai 59
Turku 59
Brussels 58
Montreal 58
Naples 58
Phoenix 55
Atlanta 54
Denver 52
Paris 52
Amsterdam 51
Bern 51
Dongguan 49
Düsseldorf 49
Brooklyn 48
Norwalk 47
Chennai 46
Sydney 46
Udine 46
Florence 45
Manchester 44
Istanbul 42
Redondo Beach 41
Kocaeli 40
Toronto 39
Baghdad 38
Boydton 38
Belo Horizonte 37
Bogotá 37
Bremen 37
Mexico City 37
Dhaka 36
Tianjin 36
Dakar 35
Jinan 35
Johannesburg 35
Venezia 35
San Francisco 34
Tashkent 33
Cividale del Friuli 32
Totale 31.969
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis. 3.328
Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease 465
Effect of cystic fibrosis sputum rheology on lungs drug delivery by inhalation 416
Acute respiratory distress syndrome 415
The Time to Offer Treatments for COVID-19 403
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 394
Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement 393
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 376
miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation 368
Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography 357
Herpes simplex virus (HSV) pneumonia in the non-ventilated immunocompromised host: Burden and predictors 328
Alveolar Epithelial Type II Cells 328
Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis 325
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion 299
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial 292
Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease. 290
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 281
Practical recommendations for diagnosis and management of respiratory muscle weakness in late-onset Pompe disease 276
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 274
Is early detection of late-onset Pompe disease a pneumologist’s affair? A lesson from an Italian screening study 269
A retrospective study of endobronchial ultrasound transbronchial needle aspiration versus conventional transbronchial needle aspiration in diagnosis/staging of hilar/mediastinal lymph node in lung cancer: Which role in clinical practice? 268
A novel approach based on low-field NMR for the detection of the pathological components of sputum in cystic fibrosis patients 263
Pregnancy in patients with tuberculosis: A TBNET cross-sectional survey 263
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 255
High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation 250
Can low field nuclear magnetic resonance be used to monitor lung functionality of cystic fibrosis patients? 249
Deep sedation versus minimal sedation during endobronchial ultrasound transbronchial needle aspiration 247
Role of the complement protein C1q in the regulation of hyaluronic acid cleavage in malignant pleural mesothelioma 245
A Multicenter Study of Post-COVID-19 Interstitial Lung Syndrome 243
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 240
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 239
Monitoring sputum properties in cystic fibrosis patients by means of Low-Field NMR before after kaftrio treatment 238
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 232
Can rheology be useful in the cystic fibrosis frame 230
Epidemiology of Tuberculosis and the Rise of XDR-TB 226
Acute respiratory failure in patients with severe community-acquired pneumonia: A prospective randomized evaluation of noninvasive ventilation 226
Keratin-14 expression in pneumocytes as a marker of lung regeneration/repair during diffuse alveolar damage 224
An adalimumab-induced late-onset immune reconstitution inflammatory syndrome treated with adalimumab 222
High-frequency percussive ventilation improves perioperatively clinical evolution in pulmonary resection 217
COMPLEMENT PROTEIN C1Q PRODUCTION IN MALIGNANT PLEURAL MESOTHELIOMA 217
Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection. 216
Combined use of rheology and portable low-field NMR in cystic fibrosis patients 215
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials 213
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 211
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 210
Towards synchrotron phase-contrast lung imaging in patients - a proof-of-concept study on porcine lungs in a human-scale chest phantom. 210
Chronic Thromboembolic Pulmonary Hypertension: An Update 209
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension 207
Use of Rheology and portable Low-Field NMR for the monitoring of lung functions in cystic fibrosis patients 198
The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung 197
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways? 197
A novel approach based on low field nuclear magnetic resonance for the detection of the pathological components of the sputum of cystic fibrosis patients 195
C1q–Ha matrix regulates the local synthesis of hyaluronan in malignant pleural mesothelioma by modulating has3 expression 195
Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study 194
Left ventricular thrombectomy in myocarditis: the epicardial scan & video-assisted transaortic approach 192
Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients 192
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 192
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 190
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 190
Reliability of noninvasive hemodynamic assessment with Doppler echocardiography: comparison with the invasive evaluation 186
Emergency Laser Treatment of a Tracheobronchial Carcinoid during ECMO 186
Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening 185
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy 183
Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach 177
Assessment of Treatment Effects of Aminaphtone by Capillaroscopy in a Patient with Raynaud’s Phenomenon 177
A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids 177
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 176
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 175
Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study 175
Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage? 175
A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation 173
184 Complement score: A novel prognostic tool in malignant pleural mesothelioma? 172
C1-inhibitor is a novel prognostic factor in malignant pleural mesothelioma and in serous ovarian carcinoma 170
Low arousal threshold: a common pathophysiological trait in patients with obstructive sleep apnea syndrome and asthma 170
The Treatment of Lung Involvement in Systemic Sclerosis 169
A preliminary open label controlled trial with bosentan in patients affected by chronic thromboembolic pulmonary hypertension (CTEPH). 168
Severity of lung involvement on chest X-rays in SARS-coronavirus-2 infected patients as a possible tool to predict clinical progression: an observational retrospective analysis of the relationship between radiological, clinical, and laboratory data 168
Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker 166
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 163
Deciphering loop gain complexity: a primer for understanding a pathophysiological trait of obstructive sleep apnea patients 162
Il supporto decisionale nei processi di acquisto dei broncoscopi monouso 162
Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) 161
Sildenafil in pulmonary arterial hypertension. 161
null 161
Burden of chronic obstructive pulmonary disease 160
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story? 159
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy 159
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 159
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study 158
Rheological and Low Field NMR Characterisation of Cystic Fibrosis Patient's Sputum 158
The value and scope of subspecialty biomedical journals: Perspectives from either side of the Atlantic. 158
Approccio pragmatico alla diagnosi di polmonite da SARS-CoV-2 (COVID-19). Dalla fase epidemica alle fasi due e tre. 158
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows 157
Corticosteroids in the treatment of severe sepsis and septic shock in adults: A systematic review 155
Complement component C1q can predict patients’ response to cisplatin depending on tumour type: A step towards personalized medicine? 154
Anemia and health performance score evaluation as decisive factors for noninvasive mechanical ventilation decisions in AECOPD: Are there new key cornerstones? 154
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair 153
Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation 151
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? 151
Added BiPAP* vs. conventional therapy in acute respiratory failure due to exacerbation of COPD. 150
Totale 25.286
Categoria #
all - tutte 152.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021880 0 0 0 0 0 0 0 0 0 396 141 343
2021/20223.205 162 240 142 239 107 187 202 144 464 319 302 697
2022/20234.120 430 488 373 472 339 654 104 309 434 66 286 165
2023/20244.444 175 153 231 183 275 447 585 770 106 228 752 539
2024/202510.212 899 1.351 982 1.058 697 637 510 514 1.001 1.019 704 840
2025/202617.355 1.493 841 1.381 2.136 1.521 1.495 2.722 1.022 2.507 2.237 0 0
Totale 49.750